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Context-Dependent Behavior of the Enterocin
Iterative Polyketide Synthase:
A New Model for Ketoreduction
and elongating molecules in the synthesis of polyaro-
matic compounds that typically range in size from oc-
taketides to dodecaketides. The KS subunit, in coordi-
nation with the KS subunit [5], has been shown to assist
in the decarboxylative priming of the malonate starter
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07745 Jena unit [6] as well as in controlling polyketide chain length
[7]. Despite the widespread occurrence of acetate-Germany
2 College of Pharmacy primed polyketides, several aromatic PKSs deviate from
the decarboxylative-priming mechanism and utilize dif-3 Department of Chemistry
University of Arizona ferent starter molecules [8]. In R1128 [9–11], daunorubi-
cin [12–14], and frenolicin [15] biosynthesis, where theTucson, Arizona 85721
respective PKS is primed with short-chain carboxylates,
KSIII and in some cases an additional ACP are involved,
leading to a functional crosstalk between fatty acid andSummary
polyketide metabolism. A different priming mechanism
is involved in oxytetracycline [16] and enterocin [17]Heterologous expression and mutagenesis of the en-
terocin type II polyketide synthase (PKS) system sug- biosynthesis, as their associated biosynthetic gene clus-
ters contain just one ACP and no KSIII homolog. Rather,gest for the first time that the association of an ex-
tended set of proteins and substrates is needed for a monofunctional CoA ligase and a dedicated AT may
function to activate and transfer the starter units malo-the effective production of the enterocin-wailupemy-
cin polyketides. In the absence of its endogenous ke- namate and benzoate, respectively, onto the PKS.
The bacteriostatic agent enterocin from “Streptomy-toreductase (KR) EncD in either the enterocin pro-
ducer “Streptomyces maritimus” or the engineered ces maritimus” is a novel type II PKS-derived octaketide
product [18] which originates from an intermediate as-host S. lividans K4-114, the enterocin minimal PKS is
unable to produce benzoate-primed polyketides, even sembled from an uncommon benzoyl-CoA starter unit
[17, 19–21] and seven malonate molecules that has un-when complemented with the homologous actino-
rhodin KR ActIII or with EncD active site mutants. dergone a rare Favorskii-like oxidative rearrangement
[22] (Figure 1). Sequence analysis of the 20 open readingThese data suggest that the enterocin PKS requires
EncD to serve a catalytic and not just a structural role frame enc biosynthetic gene cluster revealed that the
centrally located minimal PKS genes encABC are flankedin the functional PKS enzyme complex. This strongly
implies that EncD reduces the polyketide chain during by a number of genes encoding polyketide tailoring
enzymes as well as enzymes involved in starter unitelongation rather than after its complete assembly, as
suggested for most type II PKSs. biosynthesis [23]. Here, we describe the construction
and expression of a series of expression plasmids car-
rying different arrangements of enc genes and showIntroduction
that the enc minimal PKS requires an additional protein
component, namely the ketoreductase (KR) EncD, asAromatic (type II) polyketide synthases (PKSs) are com-
prised of several mostly monofunctional proteins and well as the substrate benzoyl-CoA in order to constitute
a fully functional PKS. Gene knockout and complemen-are responsible for the biosynthesis of bacterial aro-
matic natural products such as actinorhodin, tetraceno- tation experiments corroborate the heterologous bio-
synthesis results and lend support to the notion that themycin, doxorubicin, and oxytetracycline [1–3]. These
enzymes are related to type II fatty acid synthases and timing of ketoreduction in the enc type II PKS may take
place on the growing polyketide chain rather than on aform complexes containing a “minimal” set of four pro-
teins [two -ketosynthase subunits KS and KS (alter- fully extended octaketide linear intermediate. This pro-
posed pathway represents a new mechanism for typenatively referred to as the chain length factor [4]), acyl
carrier protein (ACP), and malonyl-CoA:ACP acyltrans- II PKS assembly that may be operative in other systems
as well.ferase (MAT)] that are required for polyketide chain
assembly. Additional PKS subunits, including ketore-
ductases and cyclases, have been proposed to convert
Resultsthe fully elongated, linear poly--ketoacyl thioester in-
termediate to the cyclized polyketide molecule. A large
Characterization of the enc Minimal PKSseries of novel polyketides has been generated by
by Heterologous Biosynthesismanipulating type II PKS systems that express a variety
Despite its homology to the acetate-primed act PKS,of combinations of a minimal PKS with associated pro-
the enc PKS must suppress the decarboxylative chainteins [2].
initiation by malonyl-S-ACP in favor of the benzoyl-CoAMost type II PKSs utilize malonyl-CoA as both priming
starter unit, as all natural enc-derived polyketides de-
scribed to date are benzoate primed [24]. To test*Correspondence: moore@pharmacy.arizona.edu
4These authors contributed equally to this work. whether the enc minimal PKS functions in the absence
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Figure 1. Structure and Biogenesis of Enterocin and Wailupemycins D–G
The structures of the act PKS-derived products EM18, mutactin, and dehydromutactin are provided for comparison with wailupemycins D–G.
The stereochemistry of wailupemycin D and E is relative and is unknown in EM18.
of the natural starter unit and unnaturally accepts an activate benzoate as its CoA thioester in the absence
of the benzoate:CoA ligase EncN.acetyl primer unit in its place, we constructed the
pSEK4-derived plasmid pCH8 by introducing the enc The failure of the enc minimal PKS to function in vivo
is in stark contrast to other type II PKS systems exam-minimal PKS genes encABC downstream of the actI
promoter (Table 1). This expression plasmid was intro- ined to date [2]. Even in the case of the malonamide-
primed aromatic polyketide antibiotic oxytetracyclineduced via transformation into the engineered host strain
Streptomyces lividans K4-114 [25]. Although we antici- (otc), expression of the otc minimal PKS genes with
actIII gave a reduced decaketide derived from acetatepated acetate-primed polyketides such as the octa-
ketides SEK4 [4] and SEK4b [26], the nonaketide PK8 only [30]. To test the effect of the natural enc starter
unit on polyketide assembly, we constructed another[27], or the decaketide SEK15 [28], HPLC-MS analysis
of the resulting organic extract did not reveal any polyke- pSEK4-derived plasmid carrying the encABCLMN gene
cassette (pCH16). This construct contains the machin-tide metabolites.
To evaluate whether the ActIII homologous enterocin ery for the activation of benzoic acid to benzoyl-CoA
[24] and its anticipated loading onto the enterocin ACPKR EncD is required by the enc minimal PKS for activity,
we next coexpressed the genes encABC with encD. EncC by the products of the encN and encL genes,
respectively. In addition, the oxygenase encM, pre-Two related expression systems were constructed and
evaluated. First, pCH8 was coexpressed with pCH20 viously shown to be involved in the Favorskii-like oxida-
tive rearrangement reaction [22], is present in pCH16.[23], a previously constructed encD-containing deriva-
tive of the integrating E. coli-Streptomyces shuttle plas- HPLC-MS analysis of S. lividans K4-114 (pCH16) grown
in the presence of benzoic acid, however, did not revealmid pSET152 [29]. Second, pCH8 was reengineered to
give pMP5, in which the encD gene was introduced on any benzoate-primed molecules.
To our surprise, the expression of the full complement,the same plasmid downstream of the divergent actIII
promoter. In both cases, inclusion of encD with the including both the benzoate-priming machinery (encL
and encN) and the KR encD together with the minimalencABC minimal PKS gene cassette did not facilitate
enc-based polyketide production. Supplementation with PKS genes encABC, provided benzoate-primed polyke-
tides when S. lividans K4-114 (pCH16pCH20 or pMP6)sodium benzoate did not facilitate polyketide production
either, presumably because of the host’s inability to was supplied with sodium benzoate. The enc PKS prod-
Table 1. Plasmid Constructions and Resulting Polyketide Products in the Host Strain S. lividans K4-114
Plasmid(s)a Genes Products
pCH8 encABC none
pCH8  pCH20 encABC  encD none
pMP5 encABC/encD none
pCH16 encABCLMN none
pCH16  pCH20 encABCLMN  encD wailupemycins D–Gb
pMP6 encABCLMN/encD wailupemycins D–Gb
pBM19 encABCLMN/actIII none
Transformants were grown in duplicate in the presence and absence of sodium benzoate.
a Plasmids pCH8 and pCH16 are derivatives of pSEK4 [4], pBM19 is a derivative of pRM5 [4] that contains the actIII KR gene downstream of
the divergent actIII promoter, and pMP5 and pMP6 are pRM5 derivatives that rather contain the encD KR. The integrative plasmid pCH20 for
multiplasmid expression was described previously [23].
b Only in the presence of supplied benzoic acid. Wailupemycins D and E were each produced at 5 mg/l, whereas wailupemycins F and G
were produced at 10 mg/l.
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Figure 2. Partial Maps of the Enterocin Bio-
synthesis Gene Cluster in the Wild-Type
“S. maritimus” and the Mutant “S. mariti-
mus” XD
ucts wailupemycins D–G (Figure 1), which are minor tional enterocin PKS primarily due to its catalytic or
structural properties, the encD mutant was next com-wild-type metabolites that have not undergone the oxi-
dative, Favorskii-like rearrangement reaction [22], were plemented with modified encD genes carrying mutations
corresponding to the conserved active site residues Ser-identified through comparison with authentic standards
by HPLC-MS as the major polyketides produced by the 148 and Tyr-161 (Figure 3) [32]. Single S148A and double
S148A-Y161F EncD mutations were constructed in theresulting transformants (Table 1). These benzoate-
primed wailupemycins are structurally analogous to the vectors pBM28 and pBM29, and production profiles of
the complemented encD mutants were examined byacetate-primed act PKS shunt products EM18, mutac-
tin, and dehydromutactin [2] (Figure 1). However, we HPLC-MS analysis. No polyketides, neither reduced nor
nonreduced, were detected. Assuming that the muta-were not able to detect through HPLC comparison with
standard compounds these or any other acetate-primed tions in EncD did not perturb protein structure, this ex-
periment established that the enc minimal PKS requiresmolecules from an organic extract of S. lividans K4-
114 (pMP6) when this transformant was grown in the the KR to serve a catalytic and not just a structural role
as a “linker” in the functional enc PKS enzyme complex.absence of benzoic acid. The requirement of the encD
gene product was further illuminated when the substitu-
tion of encD with the actinorhodin homolog actIII in Discussion
S. lividans K4-114 (pBM19) resulted in the loss of polyke-
tide production, thereby suggesting a definite associa- In this study, the enterocin PKS was used as a model
tion of EncD in the functional enterocin PKS complex. system to address the interactions among type II PKS
components that constitute a functional enzyme com-
plex. The heterologous expression of various combina-Construction and Complementation of the encD
Knockout Mutant “S. maritimus” XD tions of enc genes demonstrated that, in addition to the
typical elements of an aromatic minimal PKS, includingIn order to further examine the required role of the KR
EncD in the functional enc PKS complex, the encoding the KS-KSheterodimer EncA-EncB and the ACP EncC,
the functional enc PKS complex must be extended togene was disrupted in “S. maritimus” by double-cross-
over homologous recombination. Conjugal transfer of also include the KR EncD. While the heterologous ex-
pression of encABCDLMN in S. lividans K4-114 (pMP6)the pKC1139-based [31] temperature sensitive plasmid
pBM24 from E. coli to “S. maritimus” and growth of yielded the metabolic shunt products wailupemycins
D–G in the presence of exogenous benzoate, knockoutthe resulting exconjugants under selective conditions
resulted in a 512 bp in-frame deletion in the gene encD experiments suggest that the AT encL (L.X. and B.S.M.,
unpublished observations), the oxygenase encM [22],(Figure 2). PCR amplification of genomic DNA from the
wild-type strain and the encD mutant “S. maritimus” and the benzoate:CoA ligase encN [21] are not required
for minimal PKS activity. In each case, the resultingXD confirmed the gene knockout. HPLC-MS analysis of
an organic extract from the mutant verified the loss of mutants were able to biosynthesize benzoate-primed
polyketides, signifying that these enzymes are not re-production of the benzoate-primed polyketides entero-
cin and the wailupemycins, thereby corroborating the quired in the minimal PKS complex and thus do not
additionally coordinate in a functional cage of linkedin vivo expression results. Enterocin production could
be restored in the mutant upon complementation with enzymes. These and other experiments did, however,
demonstrate that the starter unit benzoyl-CoA is indeedthe wild-type encD gene in the modified pKC1139 vector
pBM26 when expressed under the control of the consti- an essential substrate, as in its absence, either in the
encP mutants “S. maritimus” KP [20] and XP [24] ortutive ermE* promoter. Complementation of the encD
mutant with the homologous actinorhodin KR gene actIII in S. lividans K4-114 (pMP6) without supplemental ben-
zoate (this study), enc-based polyketides were not pro-(pBM27), however, did not restore enterocin production,
once again suggesting a specific association of the en- duced.
The functional enc minimal PKS most likely consiststerocin minimal PKS with its endogenous KR. To evalu-
ate whether EncD is an essential component of a func- of EncABCD plus benzoyl-CoA to prime its function.
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Figure 3. Proposed Mechanism for EncD-
Catalyzed Ketoreduction
(A) Partial alignment of ketoreductases show-
ing the predicted EncD active site residues
Ser-148 and Tyr-161 that were mutated in this
work (labeled with arrow). The amino acid
numbering (140–179) relates to that of EncD.
KRs from type II PKSs include EncD (entero-
cin), ActIII (actinorhodin), DpsE (daunorubi-
cin/doxorubicin), and GraIII (granaticin). Oth-
ers include the KR domain from the type I
modular erythromycin PKS (DEBS KR6) and
the FAS KR from Escherichia coli (FabG).
(B) Based on homology modeling of short
chain dehydrogenases, the EncD active site
residues Ser-148 and Tyr-161 are predicted
to orient targeted carbonyl group in the poly-
ketide substrate for NAD(P)H reduction. The
exact chain length (pentaketide→octaketide)
of the polyketide substrate is unknown.
However, expression of EncABCD alone in S. lividans been interchanged and shown to function with hybrid
PKSs [23, 28, 33, 34], thereby leading to the hypothesisK4-114 (pMP5) or (pCH8  pCH20) when grown in the
presence of benzoate failed to produce polyketides, pre- that “the polyketide chain is completely assembled be-
fore reduction of the keto group takes place” [33]. Insumably because of the host’s inability to convert ben-
zoate to its CoA thioester. Thus, at present the smallest light of the data presented here, we propose that the
enterocin KR acts at an earlier stage in polyketide as-set of enzymes that constitutes a functional enc PKS
heterologously is EncABCDLMN. Further work is ongo- sembly, such as when the target carbonyl group is in
the  position relative to the thioester carbonyl (Figuresing to characterize the enc minimal PKS in vivo and
in vitro. 3B and 4, path B). In analogy to fatty acid assembly
by the dissociated system fatty acid synthase II [35],The enc PKS is the first reported iterative type II PKS
that has an absolute requirement for its endogenous KR polyketide biosynthesis may stall to allow for the FabG-
related EncD to reduce at the predestined pentaketidefor PKS activity and hence has an extended minimal
PKS that is context dependent. This requirement was stage. Absolutely no aberrant polyketides were ob-
served in the constructs without EncD or with inactiveinitially observed with the heterologous biosynthetic ex-
periments, in which the expression of encABCLMND EncD, however, suggesting that if chain growth termi-
nates at this stage, truncated pentaketides are not re-(pMP6) yielded polyketides (wailupemycins D–G) in the
presence of exogenous benzoate, whereas the expres- leased from the PKS complex or are simply catabolized.
The likely mode of catalysis by EncD involves its asso-sion of encABCLMN (pCH16) did not. This dependency
was corroborated in the encD mutant “S. maritimus” ciation with the KS and reduction of the KS-bound
pentaketide intermediate. The alternative, in which theXD. Polyketide productivity could only be restored in
this encD null mutant by complementation with the wild- ACP-bound pentaketide dissociates away from the KS
heterodimer followed by EncD-catalyzed reduction andtype encD gene but not with the homologous actIII gene
nor with a mutated encD* gene with single (S148A) or reassociation with the KS for further chain extension
without significant spontaneous cyclization, appearsdouble (S148A and Y161F) mutations. Based on homol-
ogy modeling of short chain dehydrogenases [32], these less likely.
One advantage of this scenario over the current modelactive site residues orient the targeted carbonyl group
in the polyketide substrate for NAD(P)H reduction (Fig- of type II PKS assembly typified in path A (Figure 4) is
that ketoreduction at an early stage (path B) facilitatesure 3). Since nonreduced polyketides of any chain length
were not generated in “S. maritimus” XD (pBM28) or in proper aldol cyclization of the first ring by limiting non-
specific cyclizations due to the deactivation of the re-S. lividans K4-114 (pCH16), these observations strongly
imply that the enc minimal PKS requires EncD to serve duced carbonyl carbon and the adjacent methylene
groups (path B). This proposed model is indirectly sup-a catalytic and not just a structural role in the functional
enc PKS enzyme complex. ported by the observation that all type II PKS-derived
polyketides engineered to date that have undergoneIn the current model for aromatic polyketide synthesis,
the timing of ketoreduction in type II PKS assembly has ketoreduction share the same regiochemistry about the
first cyclized ring, regardless of chain length [2]. In con-been proposed after the complete synthesis of the linear
poly--ketide (Figure 4, path A) [1–3]. Like enterocin trast, when KRs are omitted from type II PKSs that nor-
mally associate with KRs, the resulting engineered poly-and the wailupemycins, all ketoreduced aromatic PKS
products, including actinorhodin, frenolicin, oxytetracy- ketides include appreciable products of mixed first ring
cyclization events, as evident in the correctly folded actcline, and aclacinomycin A, are similarly reduced at the
ninth carbon from the carboxyl terminus of the assem- octaketide SEK4 versus the aberrantly folded SEK4b [26].
The act minimal PKS, as well as most other type IIbled polyketide irrespective of the polyketide chain
length (octaketide to decaketide) or the nature of the PKSs, can, however, function in the absence of its asso-
ciated KR ActIII [28, 36] as well as with KRs from otherstarter unit (acetate, butyrate, malonamate, benzoate)
[2]. Ketoreductases from these different systems have systems, including EncD [23]. In fact, inactivation of
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Figure 4. Proposed Biosynthetic Pathways to enc-Based Polyketides in “S. maritimus” Depicting the Relative Timing of Ketoreduction during
the Polyketide Assembly Process
Based on the new evidence (this study) that EncD is essential for turnover of the enc PKS, path A can be excluded, while paths B and B″
cannot yet be distinguished.
actIII in S. coelicolor A3(2) resulted in the loss of actino- tides in bacteria, including the antibiotic oxytetracy-
cline and the anticancer agent daunorubicin. Therhodin biosynthesis with concomitant production of an
as yet uncharacterized diffusible pigment [37], thereby biosynthesis of the octaketide actinorhodin has served
as a model system in type II PKS assembly, where itindicating that KR-less minimal type II PKSs can still
function and assemble the complete polyketide chain. has been shown that the minimal PKS is comprised
of a ketosynthase heterodimer, an acyl carrier proteinThe observed differences between the enc and act KRs
suggest that there may be two pathways for ketoreduc- (ACP), and a malonyl-CoA:ACP acyltransferase. The all
malonyl-CoA-derived linear octaketide product thention in type II PKS systems, either during polyketide
assembly (EncD) or post-polyketide assembly (ActIII). undergoes post-PKS modifications, including ketore-
duction, cyclization, aromatization, and oxidation re-The enterocin system strongly implies that, due to the
requirement of only a functional EncD for in vivo activity, actions, to yield the polyketide product. Several bio-
chemical processes involving the selectivity andits KR may act before the entire octaketide is biosynthe-
sized and thereby direct the cyclization regiochemistry. attachment of starter units other than acetate and the
timing of the ketoreduction and subsequent cycliza-It remains to be seen whether this new model for ketore-
duction is operative in other aromatic PKSs as well. The tion reactions during aromatic polyketide assembly
in vitro reconstitution of the enc PKS system is currently remain unsettled and were addressed in this study
being pursued to address this working hypothesis re- with the benzoate-primed enterocin PKS. Heterolo-
garding the timing of ketoreduction in type II PKS gous expression and mutagenesis of the enterocin
systems. type II PKS system suggest for the first time that the
association of an extended set of proteins (ketoreduc-
Significance tase) and substrates (benzoyl-coenzyme A) is needed
for the effective production of polyketides in the en-
terocin-wailupemycin structural family. The observedIterative type II polyketide synthases (PKSs) are re-
sponsible for the production of most aromatic polyke- dependency of the enterocin PKS on its endogenous
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pHGF7505 [41], and the HindIII-PacI fragment including the activatorketoreductase EncD strongly implies that the entero-
was exchanged with the HindIII-PacI fragments of pCH8 and pCH16,cin minimal PKS requires EncD to serve a catalytic
respectively.and not just a structural role in the functional PKS
enzyme complex. As a consequence, the apparent tim-
Construction and Characterization of the encD
ing of ketoreduction in the enterocin PKS system oc- Mutant “S. maritimus” XD
curs during the polyketide chain elongation process This mutant was obtained by gene disruption as follows. A 5.538
kb SacI-NotI fragment containing genes encIJKDAB in the naturalrather than post-PKS assembly, as proposed for most
sequence of the enc cluster from the cosmid pJP15F11 [23] wasother type II PKS systems, suggesting a new mecha-
subcloned into pGEM.5ZF (Pharmacia) to make pBM20. The 1.493nism in aromatic PKS assembly.
kb BamHI-XhoI fragment containing encD and partial encAK in
pBM20 was subcloned into XhoI-BamHI-digested pGEM.7ZF to cre-
Experimental Procedures ate pBM21. After a 512 bp NcoI-PstI internal fragment from encD
was deleted in pBM21, the remaining plasmid was blunt ended by
Bacterial Strains and Culture Conditions mung bean nuclease and then self-ligated to give pBM22. The 916
“S. maritimus” strain BD26T (GenBank accession number bp XhoI-BamHI fragment from pBM22 was used to replace the
AF233338) was grown as previously described [23]. A1 medium was analogous 1.493 kb fragment in pBM20 to create pBM23. HindIII
used for sporulation, and R2YE medium was used for isolation of and XbaI restriction sites were introduced on the ends of the 4.92
genomic DNA. S. lividans K4-114 was used as a host for transforma- kb NotI-SacI-containing encIJKD*AB fragment in pBM23 for cloning
tion with all expression plasmids [25]. Escherichia coli XL1-Blue and into the E. coli-streptomycete conjugal transfer vector pKC1139 [31]
DH5 was used for subcloning and grown in LB medium sup- digested with HindIII-XbaI to create pBM24.
plemented with ampicillin (100 g/ml) or apramycin (50 g/ml) for The plasmid pBM24 was introduced into “S. maritimus” by conju-
selection of plasmids. E. coli S17-1 was used as the host for E. coli- gal transfer via E. coli S17-1, selected on 50 g/ml apramycin at
“S. maritimus” conjugation [38]. For polyketide production, wild- 37C to get the single crossover mutant [22]. The exconjugant clone
type and mutant strains were cultivated on A1 agar plates for 5 days was inoculated into A1 broth at 37C with shaking at 250 rpm for
at 28C. S. lividans K4-114 was cultured on R2YE agar and YEME 48 hr. The resultant mycelia were used as inoculum for the next
liquid medium [39] for protoplast transformation and on 2CM for all round of culturing in the same fashion, and this process was re-
other experiments. Transformants were selected with thiostrepton peated for 3–4 rounds, at which time the cultures were diluted with
and/or apramycin in both solid and liquid medium. Individual plates water and spread on A1 plates at 37C. The colonies were randomly
were enriched with sodium benzoate (1 mM). Metabolite production plated out on A1 agar plates with and without apramycin (100 g/ml)
was monitored by LC-MS analysis of crude plate extracts and com- and incubated at 37C. Genomic DNAs from apramycin-sensitive
pared with known standards [22]. colonies were PCR amplified with the primers 5-GGTTAATTAACC
GGCCGCCCCGACGAAGG-3 (forward) and 5-GGTGGCCCCGGAC
Plasmids and General Techniques for DNA Manipulations GTCATGC-3 (reverse). 1.6 kb PCR products were indicative of re-
“S. maritimus” total genomic DNA was isolated as described [23]. vertants (wild-type) carrying a complete encD gene, whereas 1.0 kb
Cosmids pSS9A6 and pJP15F11 [23], which harbors the entire enc products corresponded to a truncated encD gene from the double-
biosynthesis gene cluster, were used as the source of DNA in the crossover mutant, designated “S. maritimus” XD (Figure 2).
construction of expression plasmids. The E. coli-Streptomyces The plate culture of the encD mutant fermented at 30C for 3
shuttle vectors pSEK4 and pRM5 [4] were used for all expression days was exhaustively extracted with 5% MeOH in EtOAc, dried
experiments in Streptomyces. Recombinant DNA procedures were over MgSO4, filtered, and evaporated to dryness. The extract was
performed by standard techniques [39, 40]. Restriction enzyme- redissolved in approximately 1 ml of MeOH, and 10 l was used for
digested DNA fragments were recovered from agarose gels with analysis by reversed-phase HPLC.
the Qiaquick DNA Purification Kit (Qiagen). Oligonucleotides were
obtained from Sigma Genosys. PCR was carried out on a PTC-2000 Complementation of “S. maritimus” XD
Peltier thermal cycler (MJ Research) with PfuTurbo (Stratagene) The mutant “S. maritimus” XD was complemented with wild-type
DNA polymerase. DNA sequencing by BigDye terminator cycle se- encD, actIII, and two mutated encD genes in the pBM25-based
quencing reaction using an ABI 377 sequencer was performed at plasmids pBM26 through pBM29, respectively. pBM25 is a deriva-
the Laboratory of Molecular Systematics and Evolution at the Uni- tive of pKC1139 containing a 0.4 kb EcoR1 fragment from pBM10
versity of Arizona. [20] containing the promoter ermE*. For pBM26, encD was PCR
amplified from the cosmid clone pJP15F11 with the primers
5-AGTACTAGTCGACGAAGGGAGAAAGTCTCAC-3 (forward) andConstruction of enc Expression Plasmids
pCH8 is a derivative of pSEK4, in which the act genes were replaced primer 5-GCTTCTAGATGGTCATGCGCGTGTCCC-3 (reverse), cloned
into pCRR-Blunt, sequence verified, digested with EcoRV and HindIII,by a 3.6 kb PacI-EcoRI encABC fragment downstream of the actI
promotor. The encABC cassette was constructed by PCR amplifica- and cloned downstream of the promoter ermE* in pBM25 to create
pBM26. For pBM27, actIII was PCR amplified from the genomiction of an encA fragment (forward primer CHPA1, CCCCTTAAT
TAAGGAGCAGAGGATGAGCGGC; bold, PacI site; reverse primer, DNA of S. coelicolor A3(2) with the primers 5-ATGACTAGTAGGGAC
CACGAGGCAGGG-3 (forward) and 5-ATGTCTAGACCGGCCGGCT7), with introduction of a PacI site upstream of the ribosomal bind-
ing site and ligation of the 0.4 kb PacI-BamHI fragment and a 3.2 GTCAGTAGTAG-3 (reverse), cloned into pCRR-Blunt, sequence ver-
ified, digested with EcoRV and HindIII in the vector, and clonedkb BamHI-EcoRI genomic fragment into the PacI-EcoRI sites of
pNEB193 (New England Biolabs), yielding pCH6. downstream of the promoter ermE* in pBM25 to give pBM27. For
pBM28 and pBM29, mutations in the gene encD, correspondingpCH16 is a derivative of pSEK4 containing a contiguous 7.3 kb
PacI-EcoRI encABCLMN cassette. In order to introduce an EcoRI to the S148A single mutant and the S148A-Y161F double mutant,
respectively, were created by PCR using the QuickChange Multi-site downstream of encN, a 5.4 kb NotI-FspI (blunted) encCLMN
genomic fragment from cosmid pSS9A6 was subcloned into NotI- mutagenesis Kit (Stratagene) with the primers 5-GATCATCAA
CATCGCGGCCACCGGCGGCAAGC-3 for exchanging S to A andSmaI of pBluescript, and the resulting NotI-EcoRI fragment was
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